CD4 and COVID-19: Nevertheless, future in vitro studies should examine whether memory CD4 T cells in PBMC, in particular cTfh, from recovered COVID-19 patients, can boost anti-spike antibodies by memory B cells in vitro, analogous to previous studies for other recall antigens (70).